Tavros Therapeutics is an emerging biotechnology company that discovers and develops therapies for cancer.
Tavros Therapeutics has raised $17.5M in total funding. The most recent round was Corporate Round. The last funding was announced in October 2022.
Tavros Therapeutics's investors include Alexandria Venture Investments, KdT Ventures, Vividion Therapeutics, Piedmont Capital Investments.
Tavros Therapeutics is headquartered in Durham, United States.
Tavros Therapeutics is an emerging biotechnology company that discovers and develops therapies for cancer.
Tavros Therapeutics is at the Corporate Round stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Tavros Therapeutics — Funding & Investors." VCBacked, October 12, 2022, https://www.vcbacked.co/company/tavros-therapeutics. Accessed August 13, 2026.
VCBacked. (2022). Tavros Therapeutics — Funding & Investors. Retrieved August 13, 2026, from https://www.vcbacked.co/company/tavros-therapeutics
{{cite web |title=Tavros Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/tavros-therapeutics |website=VCBacked |access-date=August 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated